Caricamento...
Enhanced Tumor Delivery of Gemcitabine via PEG-DSPE/TPGS Mixed Micelles
[Image: see text] Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-small-cell lung, breast, and ovarian cancers. The major deficiencies of current gemcitabine therapy, however, are its rapid metabolic inactivation and narrow therapeutic window. Herein, we employe...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Chemical
Society
2014
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3993932/ https://ncbi.nlm.nih.gov/pubmed/24579673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp4005904 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|